Single-Photon Emission Computed Tomography (SPECT) Market by Product Type (Conventional SPECT Systems, Hybrid SPECT Systems (SPECT/CT, SPECT/MRI)), By Application (Oncology, Cardiology, Neurology, Orthopedics), By End-User Industry (Hospitals, Diagnostic Centers, Research Institutions, Imaging Centers), and By Region; Global Insights & Forecast (2023 – 2030)

As per Intent Market Research, the Single-Photon Emission Computed Tomography (SPECT) Market was valued at USD 2.3 Billion in 2024-e and will surpass USD 4.6 Billion by 2030; growing at a CAGR of 12.3% during 2025-2030.

The Single-Photon Emission Computed Tomography (SPECT) market is witnessing robust growth driven by its ability to provide detailed images for diagnosing a variety of conditions. SPECT technology is pivotal in detecting and monitoring a wide range of diseases, including cardiovascular, neurological, and oncological disorders. It helps clinicians in assessing the function of various organs by tracking the distribution of radioactive tracers in the body. This market has become integral to modern healthcare, offering enhanced precision for treatment planning and disease detection. The growing demand for early diagnosis and personalized healthcare solutions is expected to continue driving market expansion over the next few years.

Conventional SPECT Systems Is Largest Owing to Cost-Effectiveness and Reliability

Among the different product types in the SPECT market, conventional SPECT systems continue to dominate due to their widespread adoption in healthcare settings. These systems are cost-effective, provide reliable results, and are suitable for a broad range of diagnostic applications. Conventional SPECT systems are particularly favored in cardiology, oncology, and neurology, where precise imaging plays a crucial role in early detection and treatment planning. The long-standing presence of conventional SPECT systems in hospitals and diagnostic centers, along with their ability to provide clear, high-quality images of organ function, ensures their continued use despite the introduction of newer hybrid technologies.

Additionally, these systems have a proven track record, which adds to their trustworthiness in clinical practices. Their affordability compared to hybrid SPECT/CT and SPECT/MRI systems makes them a preferred choice in regions with budget-conscious healthcare settings, especially in emerging markets. Conventional systems are also easy to maintain, providing cost-effective imaging solutions for healthcare facilities worldwide.

Oncology Application Is Fastest Growing Owing to Rising Cancer Incidence

In terms of applications, oncology is the fastest-growing segment within the SPECT market. With the rising global incidence of cancer, particularly in regions with aging populations, the demand for advanced imaging solutions in oncology is increasing. SPECT imaging offers a non-invasive way to evaluate the metabolic activity of tumors and assess the spread of cancerous cells. This capability is essential for treatment planning, monitoring therapeutic responses, and determining the appropriate course of action for cancer patients.

Oncology applications, especially in the detection of early-stage tumors and the monitoring of treatment progress, have been increasingly integrated into personalized medicine. As the global cancer burden rises, the need for accurate, real-time diagnostic tools such as SPECT is anticipated to grow. This trend is further bolstered by advancements in hybrid SPECT/CT technologies that allow for more precise tumor localization and staging, thereby enhancing the diagnostic capabilities of oncologists worldwide.

Hospitals Segment Is Largest Owing to Demand for Comprehensive Medical Services

The hospital sector holds the largest share in the end-user industry of the SPECT market. Hospitals are the primary healthcare providers for a wide range of diseases, making them the largest consumers of SPECT systems. These systems are used extensively for diagnostics in areas such as cardiology, neurology, and oncology, where imaging plays a key role in the treatment process. The advanced SPECT systems available in hospitals support a multidisciplinary approach to healthcare, involving various specialists for accurate disease detection and treatment.

Moreover, the increasing availability of sophisticated medical technologies in hospital settings ensures that healthcare professionals can offer the highest standard of care. Hospitals are adopting hybrid SPECT technologies, such as SPECT/CT and SPECT/MRI, for enhanced diagnostic accuracy. The integration of these systems helps streamline the workflow in hospitals, improving patient outcomes through earlier diagnosis and more precise treatment plans.

North America Is Largest Region Owing to Technological Advancements and Healthcare Infrastructure

North America dominates the global SPECT market, owing to its advanced healthcare infrastructure, technological innovations, and high adoption rate of diagnostic imaging technologies. The U.S. leads the region with its extensive use of SPECT systems in hospitals, diagnostic centers, and research institutions. The increasing prevalence of chronic diseases such as cardiovascular conditions, neurological disorders, and cancer further fuels the demand for advanced diagnostic imaging in this region.

The region’s well-established healthcare system, high disposable income, and the presence of leading medical imaging companies contribute to the growth of the SPECT market. Additionally, North America's focus on research and development in the field of nuclear medicine accelerates the adoption of newer SPECT systems, including hybrid models like SPECT/CT and SPECT/MRI. This trend is expected to continue, cementing North America's position as the largest market for SPECT technology.

Competitive Landscape

The global SPECT market is highly competitive, with several prominent players leading the way in terms of technological innovation and market share. Key players in the market include GE Healthcare, Siemens Healthineers, Philips Healthcare, and Toshiba Medical Systems. These companies are at the forefront of introducing advanced SPECT systems, including hybrid technologies such as SPECT/CT and SPECT/MRI, which provide enhanced diagnostic capabilities.

In addition to large multinational corporations, several regional players are making strides by offering cost-effective SPECT solutions tailored to local markets. These companies are focusing on product differentiation through technological advancements, such as integrating artificial intelligence for image processing and improving system efficiency. Strategic collaborations, mergers, and acquisitions are common in this space, with companies aiming to expand their product portfolios and geographic reach.

As the SPECT market evolves, competition will intensify, with an increasing focus on developing systems that improve imaging precision, reduce radiation exposure, and enhance patient comfort. The ongoing shift toward hybrid imaging systems is expected to be a key factor in the growth and competitive dynamics of the SPECT market.

List of Leading Companies:

• GE Healthcare
• Siemens Healthineers
• Philips Healthcare
• Toshiba Medical Systems
• Canon Medical Systems
• Medtronic
• Hitachi Medical Corporation
• Shanghai United Imaging Healthcare Co., Ltd.
• Neusoft Medical Systems Co., Ltd.
• United Imaging Healthcare
• Hologic, Inc.
• Accuray Incorporated
• Varian Medical Systems, Inc.
• Shimadzu Corporation
• Nihon Kohden Corporation

Recent Developments:

• GE Healthcare introduced a new advanced SPECT system with enhanced imaging capabilities and better patient comfort, aiming to improve diagnostic accuracy for cardiac and neurological diseases.
• Siemens Healthineers announced the launch of their hybrid SPECT/CT system, combining high-resolution imaging with functional data, significantly improving disease detection in oncology and cardiology.
• Philips Healthcare has made strategic partnerships to integrate artificial intelligence (AI) into their SPECT systems to provide faster image processing and more reliable diagnostic insights.
• Medtronic expanded its medical imaging portfolio by acquiring a company specializing in advanced SPECT systems, aiming to offer more comprehensive imaging solutions across multiple specialties.
• Toshiba Medical Systems received FDA approval for its new SPECT system with improved energy efficiency and lower radiation exposure, providing healthcare professionals with more precise and safe diagnostic tools.

Report Scope: